Jian Zuo

Company: Ting Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Panel Discussion: Collaborating with Large Pharma & VCs:What are They Looking For & What to Expect? 2:30 pm

Hear from large pharma, venture capitalist and experienced biotech leaders as they dive into the scientific and commercial factors of setting up a successful partnership to develop inner ear therapies Uncover the key end-to-end key milestones that are evaluated when deciding on investment and partnership opportunities Ask your questions on what big pharma companies will…Read more

day: Day 1

Developing Small Molecule Therapies from Preclinical into Clinical Trials 4:50 pm

Advancing small molecule therapies to prevent hearing loss from antibiotics, noise exposure, and chemotherapy. Translating preclinical research into clinical applications for effective drug development. Overcoming challenges in dosing, biomarkers, regulatory pathways, and trial design.Read more

day: Day 1

Advancing Preclinical Models for Inner Ear Therapeutics: Bridging Innovation & Treatment Development 1:30 pm

Current preclinical models for inner ear therapeutics face significant challenges, including limitations in replicating the complex cellular structures and functions of the cochlea, vestibular system, and auditory neurons. Key Takeaways: Examine how anatomical, cellular, and functional differences between animal models and humans affect the translation of treatments for hearing loss How to address regulatory challenges…Read more

day: Workshop Day